Abstract:Background: Perturbation of energy metabolism exacerbates cardiac dysfunction, serving as a potential therapeutic target in congestive heart failure. Although circulating free fatty acids (FFAs) are linked to insulin resistance and risk of coronary heart disease, it still remains unclear whether circulating FFAs are associated with the prognosis of patients with acute heart failure (AHF).Methods: This single-center, observational cohort study enrolled 183 AHF patients (de novo heart failure or decompensated chronic heart failure) in the Second Affiliated Hospital, Zhejiang University School of Medicine. All-cause mortality and heart failure (HF) rehospitalization within 1 year after discharge were investigated. Serum FFAs were modeled as quartiles as well as a continuous variable (per SD of FFAs). The restricted cubic splines and cox proportional hazards models were applied to evaluate the association between the serum FFAs level and all-cause mortality or HF rehospitalization.Results: During a 1-year follow-up, a total of 71 (38.8%) patients had all-cause mortality or HF rehospitalization. The levels of serum FFAs positively contributed to the risk of death or HF rehospitalization, which was not associated with the status of insulin resistance. When modeled with restricted cubic splines, the serum FFAs increased linearly for the incidence of death or HF rehospitalization. In a multivariable analysis adjusting for sex, age, body-mass index, coronary artery disease, diabetes mellitus, hypertension, left ventricular ejection fraction and N-terminal pro-brain natriuretic peptid, each SD (303.07 mu mol/L) higher FFAs were associated with 26% higher risk of death or HF rehospitalization (95% confidence interval, 2-55%). Each increasing quartile of FFAs was associated with differentially elevated hazard ratios for death or HF rehospitalization of 1 (reference), 1.71 (95% confidence interval, [0.81, 3.62]), 1.41 (95% confidence interval, [0.64, 3.09]), and 3.18 (95% confidence interval, [1.53, 6.63]), respectively.Conclusion: Serum FFA levels at admission among patients with AHF were associated with an increased risk of adverse outcomes. Additional studies are needed to determine the causal-effect relationship between FFAs and acute cardiac dysfunction and whether FFAs could be a potential target for AHF management.

Association of Serum Omentin-1 Concentrations with the Presence of Atrial Fibrillation.

Omentin-1 is associated with atrial fibrillation in patients with cardiac valve disease

Association Between Serum Afamin Levels with Nonalcoholic Associated Fatty Liver Disease

Association Of Serum Adropin With The Presence Of Atrial Fibrillation And Atrial Remodeling

Reduced Testosterone Levels in Males with Lone Atrial Fibrillation

Impact of Serum Omentin-1 Levels on Functional Prognosis in Nondiabetic Patients with Ischemic Stroke.

Association between omentin and obstructive sleep apnea: A meta-analysis

Serum Free Fatty Acids Independently Predict Adverse Outcomes in Acute Heart Failure Patients

Clinical relevance of serum omentin‐1 levels as a biomarker of prognosis in patients with acute cerebral infarction

Association between serum omentin-1 level and childhood non-alcoholic fatty liver disease

The Association Between Chinese Patients' Elevated Omentin-1 Levels, Their Clinicopathological Features, and the Risk of Colorectal Cancer.

Serum Omentin Level and Related Factors in Obese and Type 2 Diabetic Patients

Left atrial epicardial adiposity and atrial fibrillation

The Correlation of Inflammation, Oxidative Stress, and Hippocampal Perfusion in Patients with Atrial Fibrillation

Gut Microbial Metabolite Trimethylamine N-Oxide Is Related to Thrombus Formation in Atrial Fibrillation Patients.

Omega-3 Fatty Acid Biomarkers and Incident Atrial Fibrillation

Association of Serum Biomarkers and Cardiac Inflammation in Patients With Atrial Fibrillation: Identification by Positron Emission Tomography

Changes of serum omentin-1 levels in normal subjects, type 2 diabetes and type 2 diabetes with overweight and obesity in Chinese adults

Plasma proteomic analysis of association between atrial fibrillation, coronary microvascular disease and heart failure.

Serum Omentin-1 Levels in Overweight and Obese People

The association of exhaled carbon monoxide with atrial fibrillation and left atrial size in the Framingham Heart Study